CEACAM2 Antibodies

Santa Cruz Biotechnology delivers a wide array of CEACAM2 monoclonal antibodies for investigating CEACAM2 expression and function. Multiple validated applications include western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CEACAM2, a member of the carcinoembryonic antigen (CEA) family, plays a significant role in cell adhesion and signaling processes. Research has shown CEACAM2 involvement in immune responses and various pathological conditions, including cancer. Understanding CEACAM2 function continues to reveal its potential as a biomarker and therapeutic target. Researchers can utilize specific conjugates including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for enhanced detection flexibility. Current investigations focus on CEACAM2's role in cellular communication and disease progression. Ongoing studies aim to uncover novel aspects of CEACAM2 regulation and its impact on cellular pathways. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of CEACAM2's biological significance.